Results 271 to 280 of about 549,379 (280)

Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (KEYNOTE-412): a randomised, double-blind, phase 3 trial.

The Lancet Oncology
J. Machiels, Y. Tao, L. Licitra, B. Burtness, M. Tahara, D. Rischin, G. Alves, I. Lima, B. G. Hughes, Y. Pointreau, S. Aksoy, S. Laban, R. Greil, M. Burian, M. Hetnał, J. Delord, R. Mesía, M. Taberna, John N. Waldron, Christian Simon, Vincent Grégoire, K. Harrington, R. Swaby, Yayan Zhang, B. Gumuscu, B. Bidadi, L. Siu   +26 more
semanticscholar   +1 more source

Nelfinavir with concurrent chemoradiotherapy in NSCLC

The Lancet Oncology, 2019
openaire   +2 more sources

Concurrent Chemoradiotherapy Tolerated in Recurrent HNSCC

MD Conference Express, 2014
E. H. Nichols, M. Yao
openaire   +2 more sources

Induction chemotherapy plus concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: a phase 3, multicentre, randomised controlled trial.

The Lancet Oncology, 2016
Ying Sun, Wen-Fei Li, N. Chen, Ning Zhang, G. Hu, F. Xie, Yan Sun, Xiaozhong Chen, Jin-Gao Li, Xiao-dong Zhu, Chaosu Hu, Xiangying Xu, Yuanyuan Chen, Wei‐han Hu, Ling Guo, H. Mo, Lei Chen, Y. Mao, R. Sun, P. Ai, S. Liang, Guo-Xian Long, B. Zheng, Xinglai Feng, X. Gong, Ling Li, Chunying Shen, Jian-yu Xu, Ying Guo, Yu-Ming Chen, Fan Zhang, Li Lin, L. Tang, Mengzhong Liu, Jun Ma   +34 more
semanticscholar   +1 more source

Induction chemotherapy followed by concurrent chemoradiotherapy versus concurrent chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: long-term results of a phase III multicentre randomised controlled trial.

European Journal of Cancer, 2019
Qi Yang, S. Cao, Ling Guo, Y. Hua, Pei-yu Huang, Xiao-Long Zhang, Mei Lin, R. You, X. Zou, You-Ping Liu, Yu-long Xie, Zhi-qiang Wang, H. Mai, Qiu-Yan Chen, L. Tang, H. Mo, Ka-jia Cao, C. Qian, Chong Zhao, Yan-Qun Xiang, Xiu-Ping Zhang, Zhixiong Lin, Wei-xiong Li, Qing Liu, Ji-Bin Li, Li Ling, Xiang Guo, M. Hong, Ming-Yuan Chen   +28 more
semanticscholar   +1 more source

Induction chemotherapy plus IMRT alone versus induction chemotherapy plus IMRT-based concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: a retrospective cohort study

Journal of Cancer Research and Clinical Oncology, 2019
Zhi-Gong Wei, Zheng-Quan Zhang, Jin Luo, Nan Li, Xingchen Peng   +4 more
semanticscholar   +1 more source

Downstaging with Localized Concurrent Chemoradiotherapy Can Identify Optimal Surgical Candidates in Hepatocellular Carcinoma with Portal Vein Tumor Thrombus

Annals of Surgical Oncology, 2018
J. U. Chong, G. Choi, D. Han, K. Kim, J. Seong, K. Han, J. Choi   +6 more
semanticscholar   +1 more source

43 An audit of patients treated with concurrent chemoradiotherapy

Lung Cancer, 2007
openaire   +2 more sources

Comparison of Concurrent Cisplatin Chemoradiotherapy Plus Adjuvant Chemotherapy Versus Concurrent Chemoradiotherapy Alone in Locally Advanced Cervical Cancer

International Journal of Radiation Oncology*Biology*Physics, 2019
S. Chen, N.J. Yue, P. Yin, X. Ning, Haixin Huang, Y. Shen, T. Ren, H. He, Xin Wang, C. Feng, Yan Zhang   +10 more
openaire   +2 more sources

Concurrent Chemoradiotherapy

2005
openaire   +1 more source